Mainstream

Acelyrin Falls After Updating Mid Stage Trial Data For Eye Disease Drug

Acelyrin falls after updating mid-stage trial data for eye disease drug

Acelyrin falls after updating mid-stage trial data for eye disease drug

Post ContentslrnRead More

You might also be interested in reading J-Star Holding Announces Closing of Underwriters’ Over-Allotment Option in Connection with Initial Public Offering.

January 7, 2025
In Mainstream